VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,924,000 | +89.7% | 308,435 | +51.6% | 0.00% | 0.0% |
| Q1 2018 | $2,068,000 | -65.4% | 203,490 | -50.2% | 0.00% | -50.0% |
| Q4 2017 | $5,971,000 | +150.4% | 408,699 | +92.8% | 0.00% | +100.0% |
| Q3 2017 | $2,385,000 | -49.1% | 211,945 | -22.1% | 0.00% | -50.0% |
| Q2 2017 | $4,683,000 | +115.5% | 272,010 | -23.8% | 0.00% | +100.0% |
| Q1 2017 | $2,173,000 | -84.9% | 357,024 | -71.3% | 0.00% | -80.0% |
| Q4 2016 | $14,433,000 | -32.5% | 1,243,264 | +37.0% | 0.01% | -37.5% |
| Q3 2016 | $21,373,000 | +20.9% | 907,211 | +3.4% | 0.01% | +14.3% |
| Q2 2016 | $17,679,000 | +58.5% | 877,774 | +102.5% | 0.01% | +75.0% |
| Q1 2016 | $11,154,000 | -58.8% | 433,414 | +18.5% | 0.00% | -60.0% |
| Q4 2015 | $27,041,000 | -57.8% | 365,605 | +1.9% | 0.01% | -63.0% |
| Q3 2015 | $64,020,000 | -23.5% | 358,896 | -4.7% | 0.03% | -15.6% |
| Q2 2015 | $83,653,000 | -48.9% | 376,564 | -54.3% | 0.03% | 0.0% |
| Q1 2015 | $163,770,000 | +153.9% | 824,540 | +82.9% | 0.03% | +28.0% |
| Q4 2014 | $64,509,000 | -6.5% | 450,760 | -14.3% | 0.02% | -13.8% |
| Q3 2014 | $69,019,000 | +19.8% | 526,062 | +15.2% | 0.03% | +20.8% |
| Q2 2014 | $57,615,000 | -1.3% | 456,835 | +3.2% | 0.02% | -4.0% |
| Q1 2014 | $58,355,000 | +2.9% | 442,688 | -8.3% | 0.02% | 0.0% |
| Q4 2013 | $56,690,000 | +16.8% | 482,877 | +3.8% | 0.02% | +8.7% |
| Q3 2013 | $48,555,000 | +30.7% | 465,406 | +7.8% | 0.02% | +21.1% |
| Q2 2013 | $37,155,000 | – | 431,641 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |